PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF KI67 DYNAMIC CHANGE DURING PREOPERATIVE ENDOCRINE THERAPY IN BREAST CNACER PATIENTS

PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF KI67 DYNAMIC CHANGE DURING PREOPERATIVE ENDOCRINE THERAPY IN BREAST CNACER PATIENTS

Currently, there is a marked tendency towards improvement of early detection of breast cancer that allows patients at extremely low risk for developing recurrent disease to be identified. Therefore, it is necessary to search for biological markers of unfavorable prognosis for patients with hormone-d...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Rodionova, I. K. Vorotnikov, V. V. Rodionov, E. A. Dudko, N. V. Chkhivadze, V. V. Kometova, D. A. Ryabchikov, E. V. Oshkina, A. S. Ozherelyev, T. А. Bogush
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	breast cancer, hormone therapy, ki67, hormone sensitivity
Online Access:	https://www.siboncoj.ru/jour/article/view/181
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Blood biomarkers and Ki-67 proliferation marker in breast cancer
by: A. A. Studenikina, et al.
Published: (2023-04-01)

Effect of expression of immunohistochemical marker Ki-67 on the life expectancy of patients with gastric cancer 0-III stages
by: O. M. Levyk, et al.
Published: (2015-08-01)

Association between histologic grades and Ki67 score in breast cancer
by: Dr Shumaila Nawaz Khan Khan, et al.
Published: (2025-03-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
by: T. A. Bogush, et al.
Published: (2023-07-01)

The association between Ki-67 expression and survival in breast cancer subtypes: a cross-sectional study of Ki-67 cut-point in northern Thailand
by: Phanchaporn Wongmaneerung, et al.
Published: (2025-02-01)

MRI-based multiregional radiomics for preoperative prediction of Ki-67 expression in meningiomas: a two-center study
by: Ming Luo, et al.
Published: (2025-07-01)

Immunohistochemical Staining Properties of Osteopontin and Ki-67 in Feline Meningiomas
by: Gabriele Gradner, et al.
Published: (2024-11-01)

Metastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens Prolactinoma metastático: relato de caso com avaliação imuno-histoquímica para os antígenos p53 e Ki-67
by: Paulo S. Crusius, et al.
Published: (2005-09-01)

P63 and Ki-67 expression in radicular cyst
by: Mohammed Amjed Alsaegh, et al.
Published: (2023-09-01)

The importance of Ki-67 proliferation index in small cell lung cancer
by: Seda Beyhan Sağmen, et al.
Published: (2025-01-01)

Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2023-09-01)

A deep learning model to predict Ki-67 positivity in oral squamous cell carcinoma
by: Francesco Martino, et al.
Published: (2024-12-01)

RELATIONSHIP BETWEEN ARGYROPHILIC PROTEINS OF NUCLEOLAR ORGANIZER REGIONS AND ANTIGEN KI-67 WITH CLINICAL AND MORPHOLOGICAL PARAMETERS AND SURVIVAL IN LUNG ADENOCARCINOMA
by: D. S. Kobyakov, et al.
Published: (2016-02-01)

Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas
by: Zilan Luo, et al.
Published: (2025-12-01)

Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis
by: Ayla Bahramian, et al.
Published: (2024-12-01)

Prognostic Importance of Ki-67 Expression in Early-Stage Glottic Larynx Cancer Treated with Radiotherapy
by: Gül Kanyılmaz, et al.
Published: (2023-10-01)

Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas Expressão de p53, Ki-67 e c-erb B2 em adenomas hipofisários secretores de prolactina e/ou hormônio de crescimento
by: Carlos Henrique A. Botelho, et al.
Published: (2006-03-01)

Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study
by: Alper Sinanoglu, et al.
Published: (2015-06-01)

Ki67 index importance in patients with breast cancer
by: O. Bondar
Published: (2024-12-01)

Assessment of the Relationship between Ki-67 Expression and Different Clinicopathological Factors of Adenoid Cystic Carcinoma: A Retrospective Immunohistochemical Study
by: Mohammed Al Zubidi, et al.
Published: (2025-03-01)

Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023-12-01)

Interpretable model based on MRI radiomics to predict the expression of Ki-67 in breast cancer
by: Li Zhang, et al.
Published: (2025-04-01)

Preoperative multiparameter MRI‐based prediction of Ki‐67 expression in primary central nervous system lymphoma
by: Jian Xu, et al.
Published: (2025-03-01)

BIOLOGICAL MARKERS OF THE Ki-67 CELL CYCLE AND Bcl-2 IN MYOMA, ADENOMYOSIS, AND LEIOMYOSARCOMA UTERI
by: Светлана Владимировна Шрамко, et al.
Published: (2019-09-01)

Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy
by: Premkamon Aonta, et al.
Published: (2024-12-01)

The impact of stratified management of Ki-67 on the prognosis of small-cell lung cancer
by: Xiaofang Zhang, et al.
Published: (2025-07-01)

Expression of cytokeratin 7/20 and Ki67 in Helicobacter pylori-associated gastritis and intestinal metaplasia
by: Ava T Ismael, et al.
Published: (2024-07-01)

Expression of ER, PR and Ki-67 in tumor with different genetic variants of ESR and levels of antiidiotypic antibodies to steroid hormones in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2024-12-01)

A study of histopathological spectrum and expression of Ki-67, TP53 in primary brain tumors of pediatric age group
by: Subhalakshmi Sengupta, et al.
Published: (2012-01-01)

Ki-67—Playing a key role in breast cancer but difficult to apply precisely in the real world
by: Changsong Wang, et al.
Published: (2025-05-01)

The correlation between Ki-67 with other prognostic factors in breast cancer: A study in Iranian patients
by: Seyed-Hamid Madani, et al.
Published: (2016-01-01)

Study of Immunohistochemical Expression of p53 and Ki-67 in Oral Squamous Cell Carcinoma
by: Kajal Ranjan, et al.
Published: (2025-08-01)

High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
by: Hossein Schandiz, et al.
Published: (2025-01-01)

Multi-center study: ultrasound-based deep learning features for predicting Ki-67 expression in breast cancer
by: Qishan Cen, et al.
Published: (2025-03-01)

A Case of a Rapidly Progressive Small Bowel Lymphoma with High Ki-67 Expression
by: Jiyeon Yoo, et al.
Published: (2017-03-01)

Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer
by: Rabia Hursitoglu, et al.
Published: (2024-12-01)

NUCLEAR ORGANIZERS IN KI-67 POSITIVE CELLS OF SQUAMOUS CELL LUNG CANCER: CLINICAL MORPHOLOGICAL PARALLELS AND SURVIVAL
by: D. S. Kobyakov, et al.
Published: (2016-02-01)

Improving the accuracy of reporting Ki-67 IHC by using an AI tool
by: Sahil Ajit Saraf, et al.
Published: (2024-11-01)

A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor
by: Huali Li, et al.
Published: (2018-09-01)